Associate ProfessorMark Montebello

Clinical Associate Professor

Faculty of Medicine and Health

  • Clinical Associate Professor
    Faculty of Medicine and Health

RESEARCH INTERESTs

Clinical Associate Professor Montebello’s main research interests include randomised controlled trials of novel treatment interventions for substance use disorders, and improving treatments for co-morbidities occurring in people with substance use problems. Other research interests include understanding the impacts of substance use on cognition, treatment of Hepatitis C Virus in marginalised populations especially people using substances, and evaluation of Drug and Alcohol treatment services. He has received over AUD $24 million in grant funding as an investigator including nine NHMRC grants, one ARC grant and one Ramsay Research Grant. His role in Category 1 funded trials include Principal Investigator (three current) and Associate Investigator (two current, four past). He has 57 peer reviewed publications including in high impact Q1 journals such as JAMA Int Med, JAMA Psychiatry, Drug and Alcohol Dependence, and Drug and Alcohol Review. Associate Professor Montebello's work has been cited 889 times by 771 documents, and has an H-index of 15 (Scopus).

FUNDED RESEARCH

  • GRANT
    Investigating memory reliability in intoxicated witnesses of crime
    Australian Research Council (ARC)19 Oct 2023 - 30 Jun 2027
    People funded by this grant:
  • GRANT
    A randomised controlled trial of cannabidiol (CBD) in the treatment of cannabis dependence
    National Health and Medical Research Council (NHMRC)1 Jul 2022
    People funded by this grant:
  • GRANT
    A randomised, double-blind, controlled trial of MDMA-assisted therapy for comorbid alcohol use disorder and post-traumatic stress disorder
    Department of Health and Aged Care (Federal)1 Jan 2022 - 31 Dec 2026
    People funded by this grant:
  • GRANT
    A randomised controlled trial of N-acetylcysteine for the treatment of alcohol use disorder
    National Health and Medical Research Council (NHMRC)1 Jul 2021 - 31 Dec 2025
    People funded by this grant:
  • GRANT
    Randomised double-blind placebo-controlled study of lisdexamfetamine for the treatment methamphetamine dependence among adults
    National Health and Medical Research Council (NHMRC)1 Jan 2016
    People funded by this grant:
    • McKetin R,
    • Ali R,
    • Ezard N,
    • Dolan KA,
    • Dunlop AJ
  • GRANT
    An RCT of cannabinoid replacement therapy (Sativex) for preventing relapse in treatment-resistant cannabis dependent patients
    National Health and Medical Research Council (NHMRC)1 Jan 2015 - 31 Dec 2017
    People funded by this grant:
    • Bruno R,
    • Shanahan M,
    • Allsop D,
    • McGregor I,
    • Copeland J